Kenfarb & Co’s iShares US Healthcare ETF IYH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$251K Sell
4,645
-500
-10% -$27.9K 0.23% 91
2023
Q2
$288K Sell
5,145
-915
-15% -$50.8K 0.25% 89
2023
Q1
$331K Sell
6,060
-400
-6% -$21.9K 0.3% 80
2022
Q4
$367K Sell
6,460
-175
-3% -$9.66K 0.33% 71
2022
Q3
$336K Hold
6,635
0.32% 74
2022
Q2
$383K Hold
6,635
0.3% 76
2022
Q1
$383K Sell
6,635
-115
-2% -$6.42K 0.3% 76
2021
Q4
$405K Buy
+6,750
New +$386K 0.3% 75

Other funds holding IYH

Kenfarb & Co's IYH Position: Q3 2023 in Review

Kenfarb & Co reduced its iShares US Healthcare ETF (IYH) stake by 9.7% in Q3 2023, selling an estimated $27.9K and leaving 4,645 shares worth $251K. The position accounts for 0.23% of the portfolio, ranked #91.

Kenfarb & Co first reported a position in IYH in Q4 2021 and has held it in 8 quarters since. The position peaked at $405K in Q4 2021. 475 funds tracked by Wall St. Rank hold IYH as of Q3 2023.

  • Kenfarb & Co held 4,645 shares of iShares US Healthcare ETF worth $251K as of Q3 2023.
  • Kenfarb & Co sold 500 iShares US Healthcare ETF shares in Q3 2023, an estimated $27.9K.
  • iShares US Healthcare ETF made up 0.23% of Kenfarb & Co's portfolio in Q3 2023, its #91 holding.
  • Kenfarb & Co first reported a position in iShares US Healthcare ETF in Q4 2021 and has held it in 8 quarters since.
  • Kenfarb & Co's iShares US Healthcare ETF position peaked at $405K in Q4 2021.
  • 475 funds tracked by Wall St. Rank held iShares US Healthcare ETF as of Q3 2023.

Based on Kenfarb & Co's 13F filing for Q3 2023, filed 14 Nov 2023.